Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-26

Clinical Trial Update: Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine. [Phase 3]

View source ↗

Summary

This document reports the completion and results posting of a Phase 3 trial evaluating irinotecan in combination with three methods of fluoropyrimidine administ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Irinotecan (Irinotecan)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2009-11-26